323 related articles for article (PubMed ID: 23093781)
1. Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury.
Li L; Huang L; Ye H; Song SP; Bajwa A; Lee SJ; Moser EK; Jaworska K; Kinsey GR; Day YJ; Linden J; Lobo PI; Rosin DL; Okusa MD
J Clin Invest; 2012 Nov; 122(11):3931-42. PubMed ID: 23093781
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury.
Bajwa A; Huang L; Ye H; Dondeti K; Song S; Rosin DL; Lynch KR; Lobo PI; Li L; Okusa MD
J Immunol; 2012 Sep; 189(5):2584-96. PubMed ID: 22855711
[TBL] [Abstract][Full Text] [Related]
3. The promise of immune cell therapy for acute kidney injury.
Rabb H
J Clin Invest; 2012 Nov; 122(11):3852-4. PubMed ID: 23093787
[TBL] [Abstract][Full Text] [Related]
4. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma.
Day YJ; Huang L; Ye H; Li L; Linden J; Okusa MD
J Immunol; 2006 Mar; 176(5):3108-14. PubMed ID: 16493070
[TBL] [Abstract][Full Text] [Related]
5. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages.
Day YJ; Huang L; Ye H; Linden J; Okusa MD
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F722-31. PubMed ID: 15561971
[TBL] [Abstract][Full Text] [Related]
6. FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury.
Rousselle TV; Kuscu C; Kuscu C; Schlegel K; Huang L; Namwanje M; Eason JD; Makowski L; Maluf D; Mas V; Bajwa A
Front Immunol; 2020; 11():1278. PubMed ID: 32670281
[TBL] [Abstract][Full Text] [Related]
7. Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats.
Puri N; Mohey V; Singh M; Kaur T; Pathak D; Buttar HS; Singh AP
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):361-8. PubMed ID: 26728617
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.
Lappas CM; Day YJ; Marshall MA; Engelhard VH; Linden J
J Exp Med; 2006 Nov; 203(12):2639-48. PubMed ID: 17088433
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-Inducible Factor-2α Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury.
Zhang J; Han C; Dai H; Hou J; Dong Y; Cui X; Xu L; Zhang M; Xia Q
J Am Soc Nephrol; 2016 Jan; 27(1):92-106. PubMed ID: 25956511
[TBL] [Abstract][Full Text] [Related]
10. Extracellular adenosine controls NKT-cell-dependent hepatitis induction.
Subramanian M; Kini R; Madasu M; Ohta A; Nowak M; Exley M; Sitkovsky M; Ohta A
Eur J Immunol; 2014 Apr; 44(4):1119-29. PubMed ID: 24448964
[TBL] [Abstract][Full Text] [Related]
11. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.
Cao Z; Yuan Y; Jeyabalan G; Du Q; Tsung A; Geller DA; Billiar TR
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G249-58. PubMed ID: 19556359
[TBL] [Abstract][Full Text] [Related]
12. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury.
Li L; Huang L; Sung SS; Lobo PI; Brown MG; Gregg RK; Engelhard VH; Okusa MD
J Immunol; 2007 May; 178(9):5899-911. PubMed ID: 17442974
[TBL] [Abstract][Full Text] [Related]
13. Delayed Ischemic Preconditioning Attenuated Renal Ischemia-Reperfusion Injury by Inhibiting Dendritic Cell Maturation.
Zhang T; Song N; Fang Y; Teng J; Xu X; Hu J; Zhang P; Chen R; Lu Z; Yu X; Ding X
Cell Physiol Biochem; 2018; 46(5):1807-1820. PubMed ID: 29705777
[TBL] [Abstract][Full Text] [Related]
14. Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection.
Kinsey GR; Huang L; Jaworska K; Khutsishvili K; Becker DA; Ye H; Lobo PI; Okusa MD
J Am Soc Nephrol; 2012 Sep; 23(9):1528-37. PubMed ID: 22835488
[TBL] [Abstract][Full Text] [Related]
15. The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.
Chhabra P; Linden J; Lobo P; Okusa MD; Brayman KL
Curr Diabetes Rev; 2012 Nov; 8(6):419-33. PubMed ID: 22934547
[TBL] [Abstract][Full Text] [Related]
16. Tolerogenic CD11c
Wang P; Li C; Peng T; Ruan L; Wu A; Zhu J; Shi W; Chen M; Zhang T
FASEB J; 2024 Mar; 38(6):e23575. PubMed ID: 38530256
[TBL] [Abstract][Full Text] [Related]
17. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
Arrenberg P; Maricic I; Kumar V
Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
[TBL] [Abstract][Full Text] [Related]
18. Vagus nerve stimulation mediates protection from kidney ischemia-reperfusion injury through α7nAChR+ splenocytes.
Inoue T; Abe C; Sung SS; Moscalu S; Jankowski J; Huang L; Ye H; Rosin DL; Guyenet PG; Okusa MD
J Clin Invest; 2016 May; 126(5):1939-52. PubMed ID: 27088805
[TBL] [Abstract][Full Text] [Related]
19. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
20. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition.
Sevigny CP; Li L; Awad AS; Huang L; McDuffie M; Linden J; Lobo PI; Okusa MD
J Immunol; 2007 Apr; 178(7):4240-9. PubMed ID: 17371980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
